Evidence map›Paper›PMID 37789811›Full record

ArticleNanoscale2023

Covalent functionalisation controlled by molecular design for the aptameric recognition of serotonin in graphene-based field-effect transistors.

Cecilia Wetzl, Sergi Brosel-Oliu, Marco Carini, Desiré Di Silvio, Xavi Illa, Rosa Villa, Anton Guimera, Elisabet Prats-Alfonso, Maurizio Prato, Alejandro Criado

Open access · hybridAbstract read
In one paragraph

Article in Nanoscale, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Light-Modulated Humidity Sensing in Spiropyran Functionalized MoSSmall (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Cecilia WetzlCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 194, 20014, Donostia-San Sebastián, Spain. mprato@cicbiomagune.es.ORCID http://orcid.org/0000-0002-5495-2141
Sergi Brosel-OliuInstituto de Microelectrónica de Barcelona, IMB-CNM (CSIC), Campus UAB, Bellaterra, Spain. elisabet.prats@csic.es.ORCID http://orcid.org/0000-0003-0057-9887
Marco CariniCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 194, 20014, Donostia-San Sebastián, Spain. mprato@cicbiomagune.es.
Desiré Di SilvioCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 194, 20014, Donostia-San Sebastián, Spain. mprato@cicbiomagune.es.
Xavi IllaInstituto de Microelectrónica de Barcelona, IMB-CNM (CSIC), Campus UAB, Bellaterra, Spain. elisabet.prats@csic.es.ORCID http://orcid.org/0000-0002-3212-1128
Rosa VillaInstituto de Microelectrónica de Barcelona, IMB-CNM (CSIC), Campus UAB, Bellaterra, Spain. elisabet.prats@csic.es.
Anton GuimeraInstituto de Microelectrónica de Barcelona, IMB-CNM (CSIC), Campus UAB, Bellaterra, Spain. elisabet.prats@csic.es.ORCID http://orcid.org/0000-0003-1768-3293
Elisabet Prats-AlfonsoInstituto de Microelectrónica de Barcelona, IMB-CNM (CSIC), Campus UAB, Bellaterra, Spain. elisabet.prats@csic.es.ORCID http://orcid.org/0000-0002-7320-1896
Maurizio PratoCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 194, 20014, Donostia-San Sebastián, Spain. mprato@cicbiomagune.es.ORCID http://orcid.org/0000-0002-8869-8612
Alejandro CriadoCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 194, 20014, Donostia-San Sebastián, Spain. mprato@cicbiomagune.es.ORCID http://orcid.org/0000-0002-9732-513X
Instituto de Salud Carlos III · ESCIC biomaGUNE · ESIkerbasque · ESInstitut de Microelectrònica de Barcelona · ESUniversidade da Coruña · ESUniversity of the Basque Country · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last decade, solution-gated graphene field effect transistors (GFETs) showed their versatility in the development of a miniaturized multiplexed platform for electrophysiological recordings and sensing. Due to their working mechanism, the surface functionalisation and immobilisation of receptors are pivotal to ensure the proper functioning of devices. Herein, we present a controlled covalent functionalisation strategy based on molecular design and electrochemical triggering, which provide a monolayer-like functionalisation of micro-GFET arrays retaining the electronic properties of graphenes. The functionalisation layer as a receptor was then employed as the linker for serotonin aptamer conjugation. The micro-GFET arrays display sensitivity toward the target analyte in the micromolar range in a physiological buffer (PBS 10 mM). The sensor allows the in-flow real-time monitoring of serotonin transient concentrations with fast and reversible responses.

Indexed as

Aptamers, NucleotideBiosensing TechniquesGraphiteSerotoninTransistors, ElectronicAptamers, NucleotideGraphiteSerotonin

Identifiers

PMID37789811
PMCPMC10600654
OpenAlexW4386870930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.